WhaleCreep
Home › Funds › Lion Point Capital, LP › Q3 2024

Lion Point Capital, LP 13F holdings, Q3 2024

Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →

Lion Point Capital, LP disclosed 23 US equity positions worth $24.9m in its Q3 2024 13F filing. The largest position was INSM at 15.3% of the reported book, followed by GERN and ARDX.

· Q4 2024 →

What did Lion Point Capital, LP own in Q3 2024? Top 23 positions

#StockSectorWeightValueSharesΔ sharesvs prior
1 INSM INSMED INC Healthcare 15.3%$3.8m52,200 –
2 GERN GERON CORP Healthcare 11.5%$2.9m630,000 –
3 ARDX ARDELYX INC Healthcare 10.2%$2.5m370,000 –
4 MIST MILESTONE PHARMACEUTICALS IN 10.1%$2.5m1,654,154 –
5 BHVN BIOHAVEN LTD Healthcare 7.1%$1.8m35,400 –
6 KINIKSA PHARMACEUTICALS LTD 6.2%$1.5m61,400 –
7 BBIO BRIDGEBIO PHARMA INC Healthcare 5.0%$1.2m49,000 –
8 MRNS* MARINUS PHARMACEUTICALS INC 4.9%$1.2m693,778 –
9 FENC FENNEC PHARMACEUTICALS INC 4.3%$1.1m215,000 –
10 MLYS MINERALYS THERAPEUTICS INC Healthcare 3.8%$956.7k79,000 –
11 SNDX SYNDAX PHARMACEUTICALS INC Healthcare 3.6%$889.4k46,200 –
12 AVADEL PHARMACEUTICALS PLC 3.4%$839.4k64,000 –
13 BLUEBIRD BIO INC 3.3%$819.9k1,578,256 –
14 RGNX REGENXBIO INC Healthcare 2.4%$605.8k57,750 –
15 JSPR JASPER THERAPEUTICS INC 2.4%$601.9k32,000 –
16 IRON DISC MEDICINE INC Healthcare 1.5%$378.4k7,700 –
17 BENITEC BIOPHARMA INC 1.4%$358.4k39,000 –
18 ARQT ARCUTIS BIOTHERAPEUTICS INC Healthcare 1.3%$326.4k35,100 –
19 MCRB SERES THERAPEUTICS INC Healthcare 1.3%$322.4k340,761 –
20 4NX1 LUMOS PHARMA INC 0.6%$153.2k39,589 –
21 MSFT MICROSOFT CORP Technology 0.2%$43.0k100 –
22 SPRB SPRUCE BIOSCIENCES INC 0.1%$35.6k75,000 –
23 GOOG ALPHABET INC Communication Services 0.1%$16.7k100 –

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.